Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Fixed Dose Combination Pill vs Ramipril in Hypertension
NCT01005290Phase 2Terminated
- Sponsor
- Ferrer
- Start
- Oct 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sincronium in hypertension (HTN), sponsored by Ferrer. Started Oct 2009; status: terminated.
02
Drugs
Sincronium
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01005290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005290.